BioSpace News Archive

Press Releases

Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes

January 13, 2025
·
13 min read
Press Releases

Apellis Announces Keli Walbert to Join the Board of Directors

January 13, 2025
·
3 min read
Press Releases

Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates

January 13, 2025
·
11 min read
Press Releases

Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2025

January 13, 2025
·
14 min read
Press Releases

Mediar Therapeutics Enters into Global Licensing Agreement with Lilly to Advance First-in-Class WISP1 Antibody for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

January 13, 2025
·
4 min read
Press Releases

Mersana Therapeutics Announces Positive Initial Clinical Data from Phase 1 Clinical Trial of Emiltatug Ledadotin (XMT-1660); Initiation of Expansion in Triple Negative Breast Cancer

January 13, 2025
·
8 min read
Press Releases

Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)

January 13, 2025
·
5 min read
Press Releases

Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Dominant SARS-CoV-2 Variant XEC

January 13, 2025
·
13 min read
Press Releases

Bio-Path Holdings Provides 2025 Clinical and Operational Update

January 13, 2025
·
9 min read
Press Releases

Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potential Submission for U.S. Accelerated Approval for DYNE-101 in DM1 in H1 2026

January 13, 2025
·
15 min read